HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Whole Foods' Amrion Business Future Weighed

This article was originally published in The Tan Sheet

Executive Summary

Amrion may be on the selling block due to a soft supplements market and unfavorable investment results. The supplement manufacturer and direct marketer's parent company, Whole Foods Market, retained the investment banking firm Dain Raushcer Wessels to help it consider "strategic alternatives."

You may also be interested in...



Amrion shut-down

Parent company Whole Foods reports $49 mil. total loss from ailing supplement business operations in fourth quarter ended Sept. 24. Discontinued Amrion operations account for $9 mil. of the loss, Chairman & CEO John Mackey tells analysts Nov. 21, noting the company is seeking a buyer for the failed business. Whole Foods retained an investment firm to explore "strategic alternatives" for Amrion in late October (1"The Tan Sheet" Nov. 6, p. 6)

WholePeople.com, Amrion Web Business Merged With Gaiam.com

A new plan to restructure Amrion will bring profitability to the struggling dietary supplement direct marketer "by the end of fiscal year 2001," parent company Whole Foods Market predicted.

WholePeople.com Launch Aims To Revive Struggling Amrion Business

Whole Foods Market remains "optimistic" that the recent sluggish performance of its former Amrion subsidiary can be reversed with new marketing support under the WholePeople.com e-commerce venture.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133375

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel